Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate.
España S, Ochoa de Olza M, Sala N, Piulats JM, Ferrandiz U, Etxaniz O, Heras L, Buisan O, Pardo JC, Suarez JF, Barretina P, Comet J, Garcia Del Muro X, Sumoy L, Font A. España S, et al. Among authors: buisan o. Cancer Manag Res. 2020 Oct 16;12:10251-10260. doi: 10.2147/CMAR.S270392. eCollection 2020. Cancer Manag Res. 2020. PMID: 33116879 Free PMC article.
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
Ruiz de Porras V, Wang XC, Palomero L, Marin-Aguilera M, Solé-Blanch C, Indacochea A, Jimenez N, Bystrup S, Bakht M, Conteduca V, Piulats JM, Buisan O, Suarez JF, Pardo JC, Castro E, Olmos D, Beltran H, Mellado B, Martinez-Balibrea E, Font A, Aytes A. Ruiz de Porras V, et al. Among authors: buisan o. Eur Urol. 2021 Jun;79(6):722-733. doi: 10.1016/j.eururo.2020.10.001. Epub 2020 Nov 3. Eur Urol. 2021. PMID: 33153817 Free PMC article.
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Font A, Domenech M, Buisan O, Lopez H, González A, Etxaniz O, Matas M, Elias X, Gomez M, Figols M, Horneros J, Pardo JC, Notario L, Ruiz de Porras V, Perez I, Areal J, Esteve A. Font A, et al. Among authors: buisan o. World J Urol. 2022 Nov;40(11):2627-2634. doi: 10.1007/s00345-022-04147-4. Epub 2022 Sep 15. World J Urol. 2022. PMID: 36107212
Apalutamide for prostate cancer: Multicentre and multidisciplinary real-world study of 227 patients.
Sánchez JC, Picola N, Rodriguez-Vida A, Costa M, Castañeda DM, Márquez MP, Rodriguez JM, Gaya JM, Bravo A, Buisan O, Servian P, Suarez JF, Felip MM, Caparrós MJR, Asensio AA, Vilaseca A. Sánchez JC, et al. Among authors: buisan o. Cancer Med. 2023 Dec;12(24):21969-21977. doi: 10.1002/cam4.6769. Epub 2023 Dec 8. Cancer Med. 2023. PMID: 38063364 Free PMC article.
Orthotopic Robot-assisted Kidney Transplantation: Surgical Technique and Preliminary Results.
Vigués F, Etcheverry B, Perez Reggeti JI, Gaya JM, Territo A, Gallioli A, Berquin C, Basile G, Suárez JF, Fiol M, Buisan O, Riera L, Prudhomme T, Doumerc N, Pecoraro A, Breda A; European Association of Urology Robotic Urology Section Robot-assisted Kidney Transplantation Working Group. Vigués F, et al. Among authors: buisan o. Eur Urol. 2024 Jun;85(6):556-564. doi: 10.1016/j.eururo.2024.03.037. Epub 2024 Apr 15. Eur Urol. 2024. PMID: 38627151
13 results